ROBERT BINARD: Open Payments
NPI 1497429260 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 29 payments from 18 companies in 2025. Trend: 2023 $453 · 2024 $719 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $122 |
| Novo Nordisk Inc | 3 | $65 |
| Viatris Specialty LLC | 3 | $58 |
| Amgen Inc. | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| Dexcom, Inc. | 1 | $27 |
| Verona Pharma, Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
Products named: PREVNAR 20, YUPELRI, ELIQUIS, CAPLYTA, Dexcom G6 Transmitter, Wegovy, Ohtuvayre, Kerendia.
Industry payments across FL — which companies pay providers there.
